scispace - formally typeset
M

Marianne de Sèze

Researcher at University of California, Irvine

Publications -  21
Citations -  1982

Marianne de Sèze is an academic researcher from University of California, Irvine. The author has contributed to research in topics: Urinary incontinence & Overactive bladder. The author has an hindex of 11, co-authored 19 publications receiving 1817 citations.

Papers
More filters
Journal ArticleDOI

Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.

TL;DR: Intramuscular injections of BTX-A into the detrusor can provide rapid, well tolerated, clinically significant decreases in the signs and symptoms of urinary incontinence caused by neurogenicdetrusor overactivity during a 24-week study period.
Journal ArticleDOI

The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines:

TL;DR: The aim of this review of the literature, focused on identifying the risk factors of urinary tract complications in MS, is to put forward well informed considerations to help in the definition of practical guidelines for the follow-up of the neurogenic bladder in MS in order to improve its prevention and patient management.
Journal ArticleDOI

Botulinum Toxin A (Botox®) Intradetrusor Injections in Adults with Neurogenic Detrusor Overactivity/Neurogenic Overactive Bladder: A Systematic Literature Review

TL;DR: Botox injections into the detrusor provide a clinically significant improvement in adults with NDO and incontinence/NOAB refractory to antimuscarinics and seems to be very well tolerated.
Journal ArticleDOI

Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: results of a multicenter prospective study.

TL;DR: The aim of this study was to investigate the efficacy of the noninvasive technique of transcutaneous posterior tibial nerve stimulation in patients with multiple sclerosis and troublesome symptoms of an overactive bladder (OAB).
Journal ArticleDOI

Botulinum a toxin and detrusor sphincter dyssynergia: a double-blind lidocaine-controlled study in 13 patients with spinal cord disease.

TL;DR: The preliminary results of this initial randomised double-blind study clearly demonstrated the superiority of BTx compared to L in improving clinical symptoms and urethral hypertonia associated with DSD in spinal cord injured patients.